000			02011 a2200541 4500
005			20250517154654.0
264		0	_c20180322
008			201803s 0 0 eng d
022			_a1540-8183
024	7		_a10.1111/joic.12388 _2doi
040			_aNLM _beng _cNLM
100	1		_aSukul, Devraj
245	0	0	_aThe comparative safety of abciximab versus eptifibatide in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). _h[electronic resource]
260			_bJournal of interventional cardiology _cAug 2017
300			_a291-300 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAbciximab
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aBlue Cross Blue Shield Insurance Plans
650	0	4	_aContraindications, Drug
650	0	4	_aEptifibatide
650	0	4	_aFemale
650	0	4	_aHeparin _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aImmunoglobulin Fab Fragments _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMichigan
650	0	4	_aMiddle Aged
650	0	4	_aMyocardial Infarction _xtherapy
650	0	4	_aPeptides _xtherapeutic use
650	0	4	_aPercutaneous Coronary Intervention
650	0	4	_aPlatelet Aggregation Inhibitors _xtherapeutic use
650	0	4	_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors
650	0	4	_aPostoperative Complications _xepidemiology
650	0	4	_aRenal Dialysis
650	0	4	_aRetrospective Studies
650	0	4	_aTreatment Outcome
700	1		_aSeth, Milan
700	1		_aSchreiber, Theodore
700	1		_aHanzel, George
700	1		_aKhandelwal, Akshay
700	1		_aCannon, Louis A
700	1		_aLalonde, Thomas A
700	1		_aGurm, Hitinder S
773	0		_tJournal of interventional cardiology _gvol. 30 _gno. 4 _gp. 291-300
856	4	0	_uhttps://doi.org/10.1111/joic.12388 _zAvailable from publisher's website
999			_c27209365 _d27209365